International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of the Dog

Author:

Woicke Jochen1ORCID,Al-Haddawi Muthafar M.2,Bienvenu Jean-Guy3,Caverly Rae Jessica M.4ORCID,Chanut Franck J.5ORCID,Colman Karyn6ORCID,Cullen John M.7,Davis Wendell8,Fukuda Ryo9,Huisinga Maike10ORCID,Walker Ursula Junker11,Kai Kiyonori12,Kovi Ramesh C.1314ORCID,Macri Nicholas P.15ORCID,Marxfeld Heike-Antje10ORCID,Nikula Kristen J.16,Pardo Ingrid D.17ORCID,Rosol Thomas J.18,Sharma Alok K.19ORCID,Singh Bhanu P.20,Tamura Kazutoshi21,Thibodeau Michael S.22,Vezzali Enrico23,Vidal Justin D.24,Meseck Emily K.25ORCID

Affiliation:

1. Scottsdale, AZ, USA

2. Pathology, Research and Development, Bristol-Myers Squibb, New Brunswick, NJ, USA

3. Charles River Laboratories Montreal ULC, Senneville, Quebec, Canada

4. GlaxoSmithKline, Collegeville, PA, USA

5. Preclinical Safety, Sanofi, Chilly Mazarin, France

6. Genomics Institute for the Novartis Research Foundation, La Jolla, CA, USA

7. North Carolina State University College of Veterinary Medicine, Raleigh, NC, USA

8. Alnylam Pharmaceuticals, Cambridge, MA, USA

9. Axcelead Drug Discovery Partners, Inc, Fujisawa, Kanagawa, Japan

10. BASF SE, Ludwigshafen, Germany

11. Olten, SO, Switzerland

12. Daiichi Sankyo Co, Ltd, Medical Safety Research Laboratories, Edogawa-ku, Tokyo, Japan

13. Experimental Pathology Laboratories (EPL), Inc, Research Triangle Park, NC, USA

14. National Toxicology Program (NTP), US National Institute of Environmental Health Sciences (NIEHS), Research Triangle Park, NC, USA

15. Covance Laboratories Inc, Somerset, NJ, USA

16. Inotiv, Maryland Heights, MO, USA

17. Global Pathology, Pfizer Inc, Groton, CO, USA

18. Ohio University Heritage College of Osteopathic Medicine, Athens, OH, USA

19. Covance Laboratories Inc, Madison, WI, USA

20. Gilead Sciences, Inc, Foster City, CA, USA

21. Pathology Department, BoZo Research Center Inc, Shizuoka, Gotemba, Japan

22. Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA

23. Idorsia Pharmaceuticals, Allschwil, Switzerland

24. Charles River Laboratories, Mattawan, MI, USA

25. Novartis Pharmaceutical Corporation, East Hanover, NJ, USA

Abstract

The INHAND (International Harmonization of Nomenclature and Diagnostic Criteria for Lesions) Project ( www.toxpath.org/inhand.asp ) is a joint initiative of the societies of toxicologic Pathology from Europe (ESTP), Great Britain (BSTP), Japan (JSTP), and North America (STP) to develop an internationally accepted nomenclature for proliferative and nonproliferative lesions in laboratory animals. The purpose of this publication is to provide a standardized nomenclature for classifying lesions observed in most tissues and organs from the dog used in nonclinical safety studies. Some of the lesions are illustrated by color photomicrographs. The standardized nomenclature presented in this document is also available electronically on the internet ( http://www.goreni.org/ ). Sources of material included histopathology databases from government, academia, and industrial laboratories throughout the world. Content includes spontaneous lesions, lesions induced by exposure to test materials, and relevant infectious and parasitic lesions. A widely accepted and utilized international harmonization of nomenclature for lesions in laboratory animals will provide a common language among regulatory and scientific research organizations in different countries and increase and enrich international exchanges of information among toxicologists and pathologists.

Publisher

SAGE Publications

Subject

Cell Biology,Toxicology,Molecular Biology,Pathology and Forensic Medicine

Reference247 articles.

1. Global Open Registry Nomenclature Information System. https://www.goreni.org/

2. Society of Toxicologic Pathology. Published 2020. Accessed November 3, 2020. https://www.toxpath.org

3. International Harmonization of Toxicologic Pathology Nomenclature

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3